kelompok controlnegatif (22,91±3,21x10 4 cells/mL) (p<0.05). Pada inkubasi 24 jam, migrasi sel kelompok AV500 (78,13±7,18%), AV250 (73,88±4,75%) and AV125 (68,80±17,11%) lebih tinggi secara nyata dibandingkan kelompok kontrolnegatif (53,91±2,74%) (p<0.05). Sebaliknya pada inkubasi 48 dan 72 jam, tidak terdapat perbedaan migrasi sel secara nyata(p>0,05). Ekspresi VEGF-A dan JNK-1 setelah inkubasi dengan AV500 selama 48 jam lebih tinggi secara nyata dibandingkan dengan kelompok kontrol negatif (p<0,05). Dapat disimpulkan, lidah buaya dapat meningkatkan ekspresi VEGF-A dan JNK-1 sel fibroblastkulit tikus diabetes.
INTRODUCTION
Patients with diabetes mellitus (DM) can develop neuropathy which can cause diabetic foot ulcer. The neuropathy caused by disruption of vascular system and sensory nerve damage in extremities area leads to loss of sensation and skin integrity damage. 1, 2 This is a port ofthe entry for microbe to cause a chronic wound, which is difficult to cure. Moreover patients with severe diabetic foot ulcer can be amputated. 3 Hyperglycemia condition changes metabolism of tissue connection because of disturbance in synthesis process and increased the speed of collagen degradation, which results to delayed wound healing process. 4, 5 Delayed diabetic wound healing is related to low number of vascular endothelial growth factor (VEGF) expression and other growth factors which are the main factors of angiogenesis, cell proliferation, and cell migration on wound healing process. 3, 6 Cell migration activity decreased in hyperglycemia due to the excessive production of reactive oxygen species (ROS) that causes oxidative stress and DNA damage, also failure in cell function. [7] [8] [9] [10] Hyperglycemia obstructs c-Jun N-terminal kinase(JNK) phosphorylation which is the downstream of VEGF, as a result there are disturbance on migration activity and cell proliferation. 9, [11] [12] [13] Aloeveraisa medicinal plant traditionally used to treat acute or chronic wound. 14, 15 Topical form of A.vera can accelerate healing process of diabetic wound and plays a role in all stages of wound healing process. 4, 16 Aloevera is nontoxic and can maintain or increase epithelial cell and fibroblast cellviability. 17, 18 Aloevera contains variety of active compounds such as aloe emodin, β-sitosterol, and acemannanwhich can stimulate VEGF production in ischemia reperfusion damaged brain of Mongolian gerbil and fibroblast cellculture of gingival rats. 19, 20 Aloe veraoral administration significantly stimulates production of TGF-β1 and bFGF on wound radiation and increases wound contraction, and increase fibroblast migration, also endothelial cells. 21 This studyaimed to invetigate the effect of A. vera ethanol extracton cell proliferation, cell migration, VEGF-A and JNK-1 expression of fibroblast cell culture of diabetic rat skin.
MATERIALS AND METHODS

Preparation of A. vera ethanolic extract
Aloe verabarbadensis Millerwas collected from Unit Pelaksana Teknis Daerah(UPTD) Agribisnis Pontianak, West Borneo, Indonesia. The extract was prepared according to Moniruzzaman et al. 22 after modification. The leaves of A. vera were washed in several times then chopped and homogenized by using blender. About one kg ofA. verawasmacerated using two L of 80% ethanol for24 h. The macerates were then evaporatedunder reduced pressure using a rotary evaporator. The semi-dried ethanol extract was then freeze-dried at-55 o C and transferred to a reagent bottle to be stored in a freezerat-8 o C.
Phytochemical screening
The ethanolic extract of A.verawas subjected to various qualitative tests for identification ofitsconstituentsusing thin-layer chromatography (TLC). Separation was performed using silica gel GF 254 as the stationary phaseand mixture of chloroform : methanol : ethyl acetate (5:1:1,v/v/v) as mobile phases. The chromatogram was observed under UV light atwave length 254 and 366 nm and sprayed with citroborateto detect flavonoids in the extract. Mannose examination was performed using high performance liquid chromatography (HPLC). Sample was added one g to volumetric flask and added 10 mL H 2 O, furthermore vortexedandcentrifugedat 10.000 rpm for 5 min. The product was filtered by Millex 0.45 µm and injected to HPLC as much 50 µL. The chromatographic separation was conducted with MetaCarb 87P columnkept in column oven at 85 o C, H 2 O as mobile phase at a flow rate of 0.6 mL/ min and RID detector for detection.
Animal preparation
Protocol of the study has been approvedby the Medical and Health Research Ethics Committee (MHREC), Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada (ref. KE/FK/422/EC/2016). Male albino rats of the Wistar strain weighing ±200 g obtained from the Department of Pharmacology and Therapy, Public Health and Nursing, Universitas Gadjah Mada were maintained on standard rat feed and water ad libitum. The animals were fasted for 12 h but had been allowed free access to water. After fasting, DM was induced by intraperitoneal injection of streptozotocin 60 mg/kg body weight (BW) and nicotinamide 120 mg/kgBW in 0.05 M dissolved in citrate buffer (pH 4.5). 23 After three days, blood glucose level were measured and only animal with glycaemia higher than 250 mg/dL were considered diabetic.
Fibroblast cell isolation and culture
Rats were sacrificed with an overdose of ketamine and xylazine. Fibroblast cells were isolated according to Seluanov et al. 24 after modification. Underarm skin area of animal were shaved and dissected to collect skin samples. Skin wascutapproximately 6 cm 2 using sterile technique and cultured using explant method. The cells were cultured under standard conditions, with Dubelco's modified Eagle's medium (DMEM low glucose) containing 10% fetal bovine serum (FBS), 1% penstrep, and 0.5% fungizone (GIBCO ® , Grandlisland, NY, USA), then incubated at 37°C and 5% CO 2 . The medium was changed thrice a week and cells were trypsinized at 80% confluence. Passages 4-7 of cell were used for all experiments. The sample then divided into six groups i.e. KN asnormal fibroblast cell + low glucose medium (5 mM); K(+) asfibroblast of diabetic rat + high glucose medium (25 mM) + Algisite-M ® dressing; K(-) asfibroblast of diabetic rat + high glucose medium (25 mM); AV500 asfibroblast of diabetic rat + high glucose medium (25 mM) + A. vera 500 µg/mL; AV250 asfibroblast of diabetic rat + high glucose medium (25 mM) + A. vera 250 µg/mL; AV125 asfibroblast of diabetic rat + high glucose medium (25 mM) + A. vera 125 µg/mL.
Preparation of solution
About 5 mg of the ethanolic extract of A. vera was diluted in 100 μL dimethyl sulphoxide (DMSO; SIGMA ® ; St Louis, MO, USA) to obtain a stock solution (50.000 μg/mL) and then dissolved inhigh glucose medium (DMEM 25 mM glucose, FBS 10%, penstrep 1%, fungizone 0.5%) and created in various concentration of A. vera (500, 250, 125µg/mL). Algsite-M ® dressing extractsolution was created by using 2 cm 2 of Algsite-M ® dressing (Smith & Nephew ® ) and incubated in 8 mL of high glucose medium at 37°C for 24 h.Positive control (Algsite-M ® ) was used for each assay.
Cell proliferation examination
Cell proliferation examinationwas performed by counting the number of cells in hemocytometer slide Neubauer. Cells were seeded in microplate-96 wells with 10 4 cells/mL per well in volume 100 µL, and incubated in high glucose medium (DMEM 25 mM glucose) for 24 hours at 37°C and 5% CO 2 . Furthermore, cellswere incubated with A. vera extract concentration 500, 250, 125µg/mL and Algisite-M ® extract in high glucose medium. The number of cells was then counted in 24, 48 and 72 h after incubation.
Cell migration examination
Cell migration test carried out using in vitro scratch assay method. The number of cells to examine cell migration was5x10 4 cells per sampleinmicroplate-24 well. Cells were incubated in high glucose medium (DMEM 25mM glucose) at 37°Cand 5% CO 2 for 24 h . Furthermore, cells were incubated with A. veraextract concentration 500, 250, 125µg/mLand Algisite-M ® extract in high glucose medium after creating a wound across the cell monolayer with a yellow plastic tip. Cell migration into the wound surface was then measured after 24, 48, 72 h after incubation and analyzed byImageJ program.
Expression of VEGF-A and JNK-1 examination
The number of cells to examine VEGF-A and JNK-1 expression was 2x10 5 cells/mL per well in volume one mL. Cells were incubated in high glucose medium (DMEM 25mM glucose) at 37°C and 5% CO 2 for 24 h. Furthermore, cells were incubated with A. vera extract concentration 500, 250, 125µg/mL and Algisite-M ® dressing in high glucose medium and incubatedat 37°C and 5% CO 2 for 48 h. Total RNA isolated by using RNA ISO Plus or GENEzol™ (GZR100) with recommended procedures. RNA were quantified by using spectrophotometer. PCR cDNA mixwere carried out bymixed 5x buffer (Toyobo, Cat. No. TRT-101), random primer (TaKaRa, Cat. No. 3801), deoxyribonucleotide triphosphate (dNTP) (TaKaRa, Cat. No. 4030), and Rever TraAce (Toyobo, Cat. No. TRT-101). cDNA product, PCR water, and PCR mixture were mixed and carried out PCR running with conditions: denaturationat 30°C (10 min), annealingat 42 o C (60 min), and extension at 99°C (5 min).Gene amplification was performed by using polymerase chain reaction (PCR) method with specific primer. GoTaq ® Green Master Mix (Promega, USA) in 12.5 μL were used to amplifications andusing total reaction volume total 25μL. Furthermore, 10μL amplification productswere visualized by using electrophoresis. 
Statistical analysis
Statistical analysis was carried out with the SPSS programfor windows. Datawere expressed as the mean ± standard deviation (SD). The differences among the mean values from four independent experiments were analyzedwith one-way ANOVA followed by post hoc LSD test analysis. A p value <0.05 was considered significant. 
RESULTS
Phytochemical screeningof A. vera
Cell proliferation
Cell proliferation is presented in FIGURE 2 . The cell proliferation of the negative control groupafter 24, 48, 72 h incubations were significantly lower than that normal fibroblast cell group (p<0.05). The cell proliferation of the AV500 and AV250 groups after24 and 48 h incubations were higher than that the negative control group, but they were not significantly different (p>0.05). However, after72 h incubation, significantly different between AV500, AV250, and AV125 groupscompared to that the negative control groupwas observed (p< 0.05). FIGURE 2. Cell proliferation (mean ± SD 10 4 cells/mL) after 24, 48 and 72 h incubations.One way ANOVA examinationin 24h (p = 0.001),48 h (p = 0.000)and 72 h (p = 0.000).Post hoc LSD: a (p < 0.05) compared to positive control; b (p < 0.05) compared to negative control; c (p < 0.05) compared to normal fibroblast cell control.
Cell migrtion
The cell migration of the normal fibroblast cell groupafter 24 h incubation was highestcompared toall of the groups (p<0.05). The cell migration of the AV500, AV250 and AV125 groupafter 24 h incubation was significantlyhigher thanthat the negativecontrol group (p<0.05). However, after 48 and 72 h incubation, no significantly different in all groups were observed (p>0.05).It was indicated that scratch wound has closed at the hour 48 after treatments. The cell migration of all groups arepresented inFIGURE 4. 
VEGF-Aexpression
The normal fibroblast cell control group showed highest VEGF-A/GAPDH expression compared to all of the groups (p<0.05).The AV500 group had higher VEGF-A/GAPDH expression compared to that positive control, negative control, AV250, andAV125 groups(p<0.05). 
VEGE-A
JNK-1 expression
The normal fibroblast cell control groups howed highest JNK-1/GAPDH expression compared to all of the groups (p<0.05). The AV500 group had higher JNK-1/GAPDH expression compared to that negative control, AV250, and AV125group(p<0.05). 
DISCUSSION
In this study, hyperglycemia condition caused cell proliferation and cell migration disturbances, also decreased VEGF-A and JNK-1 gene expression on fibroblast of diabetic rat. It was indicated by significantly fewer cell proliferation of the negative control group compared to that control normal group after 24, 48 and 72 h incubations (p<0.05). In addition, cell migration of negative control group was significantly lower compared to that control normal group (p=0.000) and the scracth wounds of control normal group was almost completely closed compared to the other groups. The VEGF-A and JNK-1 gene expression of negative control group after 24 h incubation was significantly lower compared to that normal control group (p=0.000).
The result of this study was supported by previous studies which confirmed that hyperglycemia condition causedthe cell proliferation and cell migration disturbance. 7, 8, 11, 12 Moreover, hyperglycemia condition can diminish VEGF production and JNK phosphorylation lead to disturbance of cell proliferation and cell migrationon wound healing process. 8, 10, 13 The impairment of cell proliferation on hyperglycemia can caused by several factors such as increase of L-lactate production, 11 inflammatory mediators and advanced glycation end-product (AGE) which is stimulate apoptosis through activation of ROS, pro-apoptotic transcription factor FOXOI and caspase 3. 12 The increase of ROS production affectsthe protein structure and function, as well asinhibition ofcell migration directly by over-activation of the small Rho GTPase Racl and altered polarity and morphology of cells. 7, 13 Diminished VEGF production on hyperglycemia occurs by inhibition of JAK-2 and STAT3 (Signal transducer and activator of transcription-3). 25 Hyperglycemia obstructs JNK phosphorylation which is the downstream of VEGF, as a result there are disturbance on cell proliferation and cell migration. [11] [12] [13] 26 Ethanolic A. veraextract can stimulate proliferation and migration of fibroblast cell of diabetic rat in this study. The cell proliferation after 24 and 48 h incubations with A. vera extract at concentration of 500 and 250 µg/mL were higher than that the negative control group, but they were not significantly different (p>0.05). However, after 72 h incubation, significantly different between A. veraextract at concentration of 500, 250 and 125 µg/mL compared to that the negative control group was observed (p < 0.05). The cell migration after 24 h incubation with A. vera extract at concentration of 500, 250 and 125 µg/ mL were significantly higher than that the negative control group (p <0.05).The result of this study was also support by the previous studies whichconfirmed that A. vera can increase cell proliferation and cell migration. 17, 27 The increase of cell proliferation and cell migration occurred in concentration dependent manner. The scratches wounds almost completely closed in each group after 48h incubation. The increase of the cell migration activity is likely occurred before 24 h incubation, so after 24 h the migration has been achieved>50% in each group.
The VEGF-A and JNK-1 expressions after incubation with A. vera extract at concentration of 500 µg/mL were significantly higher compared to that the negative control group (p<0.05). It was indicated that A. vera can stimulate VEGF production and the other growth factors which has a role in wound healing process as previously reported. 20, 28 The incubationof A.vera extract at concentrationof 250 and 125 µg/mL on the VEGF-A and JNK-1 expressionswere not significantly different compared to the negative control. This may be related to the small concentrations that do not affect the increased expression of VEGF-A and JNK-1.
The glycoproteins and polysaccharides components in A.vera can trigger cell growth and significantly increase cell proliferation and cell migration by stimulating TGF-β1 and bFGF production, also affecting Gap junctional intercellular communication (GJIC) which is the important factors in growth of tissue and organs. 28, 29 Aloesincompound of A. vera stimulates cell growth through induce cell cycleprotein regulatorsuch ascyclin E, cyclin dependen kinase-2 (CDK2), and cell division cycle-25A (CDC25A) which synergistically up-regulate the cyclin E/CDK2 kinase activity. 30 β-Sitosterol compound of A. vera increase VEGF expression onbrain ischemic reperfusion animals. 27 The phytochemical analysis of the A.veraextract by TLC showedthe presence of compounds on length of wave 366 nm withRf value of 0.32; 0.45; 0.64; 0.84; and 0.90.It was indicated that A.vera extract has various compounds that taken along by mobile phase with various distance based on polarity of compounds. Citroborate spraying was used to examine of flavonoid existence in the A.vera extract. The major polysaccharide compound of A. vera is acemannan (mannose-6phosphat) which is composed of one or more polymers of various chain length with molecular weights 30-40 kDa and consists of repeating units of glucose and mannose. 31 In this research, mannose compound was analyzed byusing HPLC and had mannose content <32 µg/gr. Previous studies reported that A. vera accelerates diabetic wound healing 4, 16 by increase the glycosaminoglycans (GAGs), and plasma insulin level, also diminish blood glucose level. 32 Acemannan accelerates oral and diabetic wound healingof animal modelsby stimulates KGF-1, VEGF production, collagen synthesis, and also increase collagen cross link activity for wound contraction. 20, 28 The active accemanan should bind to mannose receptor on the cell surface by recognize polysaccharide chains terminating with mannose, fucose or N-acetylglosamine and stimulate growth factor production and cell proliferationby induce the intracellular signaling pathway. 20,33 Acemanan promotes skin wound healing and accelerates cell proliferation through stimulate synthesis of protein translationcyclin D1 which is mediated by AKT/mTOR signaling pathway. 34 Antioxidant activity of A. vera like flavonoid significantly decreases ROS, lipid peroxidase and glycosylated hemoglobin level which are the cause of cell proliferation and cell migration impairment, also diminished of VEGF on diabetic wound. 7, 10, 35 This antioxidant activity also has a role in radical scavenging by increase in activity ofsuperoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) enzymes. 7, 10, 35 
CONCLUSION
Ethanolic extract of A. vera increases cell proliferation, cell migration, VEGF-Aand JNK-1expression onfibroblast cell cultured of diabetic rat skin.
